» Articles » PMID: 25961290

Extraction of Pharmacokinetic Evidence of Drug-drug Interactions from the Literature

Overview
Journal PLoS One
Date 2015 May 12
PMID 25961290
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Drug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of intense scientific interest. Biomedical literature mining can aid DDI research by extracting evidence for large numbers of potential interactions from published literature and clinical databases. Though DDI is investigated in domains ranging in scale from intracellular biochemistry to human populations, literature mining has not been used to extract specific types of experimental evidence, which are reported differently for distinct experimental goals. We focus on pharmacokinetic evidence for DDI, essential for identifying causal mechanisms of putative interactions and as input for further pharmacological and pharmacoepidemiology investigations. We used manually curated corpora of PubMed abstracts and annotated sentences to evaluate the efficacy of literature mining on two tasks: first, identifying PubMed abstracts containing pharmacokinetic evidence of DDIs; second, extracting sentences containing such evidence from abstracts. We implemented a text mining pipeline and evaluated it using several linear classifiers and a variety of feature transforms. The most important textual features in the abstract and sentence classification tasks were analyzed. We also investigated the performance benefits of using features derived from PubMed metadata fields, various publicly available named entity recognizers, and pharmacokinetic dictionaries. Several classifiers performed very well in distinguishing relevant and irrelevant abstracts (reaching F1≈0.93, MCC≈0.74, iAUC≈0.99) and sentences (F1≈0.76, MCC≈0.65, iAUC≈0.83). We found that word bigram features were important for achieving optimal classifier performance and that features derived from Medical Subject Headings (MeSH) terms significantly improved abstract classification. We also found that some drug-related named entity recognition tools and dictionaries led to slight but significant improvements, especially in classification of evidence sentences. Based on our thorough analysis of classifiers and feature transforms and the high classification performance achieved, we demonstrate that literature mining can aid DDI discovery by supporting automatic extraction of specific types of experimental evidence.

Citing Articles

Leveraging deep learning to detect stance in Spanish tweets on COVID-19 vaccination.

Blanco G, Yanez Martinez R, Lourenco A JAMIA Open. 2025; 8(1):ooaf007.

PMID: 40008184 PMC: 11854073. DOI: 10.1093/jamiaopen/ooaf007.


Named entity recognition of pharmacokinetic parameters in the scientific literature.

Gonzalez Hernandez F, Nguyen Q, Smith V, Cordero J, Ballester M, Duran M Sci Rep. 2024; 14(1):23485.

PMID: 39379460 PMC: 11461509. DOI: 10.1038/s41598-024-73338-3.


Multiple sampling schemes and deep learning improve active learning performance in drug-drug interaction information retrieval analysis from the literature.

Xie W, Fan K, Zhang S, Li L J Biomed Semantics. 2023; 14(1):5.

PMID: 37248476 PMC: 10228061. DOI: 10.1186/s13326-023-00287-7.


Biomedical named entity recognition with the combined feature attention and fully-shared multi-task learning.

Zhang Z, Chen A BMC Bioinformatics. 2022; 23(1):458.

PMID: 36329384 PMC: 9632084. DOI: 10.1186/s12859-022-04994-3.


Detecting Drug-Drug Interactions in COVID-19 Patients.

Jeong E, Person A, Stollings J, Su Y, Li L, Chen Y Stud Health Technol Inform. 2022; 290:330-334.

PMID: 35673029 PMC: 9208760. DOI: 10.3233/SHTI220090.


References
1.
Niska R, Bhuiya F, Xu J . National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010; (26):1-31. View

2.
Huang M, Neveol A, Lu Z . Recommending MeSH terms for annotating biomedical articles. J Am Med Inform Assoc. 2011; 18(5):660-7. PMC: 3168302. DOI: 10.1136/amiajnl-2010-000055. View

3.
Abi-Haidar A, Kaur J, Maguitman A, Radivojac P, Rechtsteiner A, Verspoor K . Uncovering protein interaction in abstracts and text using a novel linear model and word proximity networks. Genome Biol. 2008; 9 Suppl 2:S11. PMC: 2559982. DOI: 10.1186/gb-2008-9-s2-s11. View

4.
Duke J, Han X, Wang Z, Subhadarshini A, Karnik S, Li X . Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol. 2012; 8(8):e1002614. PMC: 3415435. DOI: 10.1371/journal.pcbi.1002614. View

5.
Hennessy S, Flockhart D . The need for translational research on drug-drug interactions. Clin Pharmacol Ther. 2012; 91(5):771-3. PMC: 4340251. DOI: 10.1038/clpt.2012.39. View